Earnings Week Kicks Off With Bears on Alert

Markets open August with a heavy earnings calendar, rising short pressure in beaten-down names, and options traders positioning defensively across tech.

Earnings Week in Focus

The week's biggest catalyst is a packed S&P 500 reporting schedule. MAR kicked things off this morning. AMGN and BKNG report Tuesday after the close. AMGN's $209bn biotech weight makes it the must-watch print. BKNG at $150bn will give a clear read on global travel demand. Pharma names BIIB and REGN also drew analyst target upgrades today. Biotech rotation is building ahead of results.

Short Sellers Dig In

Bears pushed hard into three high-profile names this week. HTZ sits at 84.6% SI % FF. Availability has hit zero — no shares left to borrow. Squeeze risk is elevated. CHWY is close behind at 82.4% SI % FF, up 10 percentage points in seven days. Cost to borrow remains cheap at 0.5%, so shorts can still add easily. GRPN rallied 96% over three months yet bears won't back off — short interest hit 74.3%.

Options Flow Flashes Red

MU tops the negative options flow leaderboard. The chip stock is up 206% year-to-date. Traders are buying downside protection ahead of its Q3 results. TSLA is near oversold territory with an RSI of 30.56. It's down 31% for the year. Options bears are active despite analysts seeing 29% upside.

Insiders Sell, Analysts Revise

Charles Schwab filed sales totalling $19.8M in SCHW shares between July 24 and July 29. Citizens Financial CEO Bruce Van Saun filed a $9.3M disposal. On the analyst side, HAS and pharma names received target lifts. MLM was a rare downgrade as infrastructure spending momentum fades.